National Forum on

Pharmaceutical Pricing Litigation

Developing cutting-edge litigation strategies in response to a new wave of pricing cases in AWP, AMP, BP, and more

Tuesday, October 02 to Wednesday, October 03, 2012
Carlton Hotel, New York, NY
​The stakes in pricing cases are increasing every year. Plaintiffs are devising increasingly sophisticated theories and causes of action. State governments are retaining and deputizing private outside counsel.
Come to the only event that will help you make sense of it all.

Theories and causes of action in pharmaceutical pricing cases are becoming more complex and creative, as the tried and true standard pricing methodology of AWP is waning.  Examine the cutting edge trends and shape a litigation strategy that will prepare you for the new wave of pricing cases at ACI’s National Forum on Pharmaceutical Pricing Litigation. This conference will provide winning strategies for all aspects and facets of drug pricing litigation, i.e., theories, causes of actions, successful defenses, government negotiations, etc.

Recent settlements have been in the hundreds of millions - Learn how to adapt your trial strategy to prepare for the new wave of pricing cases

Obtain a competitive advantage by coming to this forum and joining the conversation between state and federal prosecutors (including “deputized” outside counsel retained by states), state attorneys general, and expert counsel.  This all star faculty will help you:

•    Develop defense responses to AWP litigation despite the lack of a statutory definition of "average"
•    Bolster your trial strategy to mitigate exposure in litigation over AMP calculations in light of proposed changes from CMS
•    Understand the current CMS position, as they try to clarify the complex set of best price rules and guidance from the early 2000s
•    Shape defense strategy in response to the increase of qui tam and whistleblower cases proceeding to trial
•    Distinguish between pricing FCA cases and off-label cases to improve litigation tactics
•    Adjust trial strategy to account for cases litigated by state-appointed private outside counsel
•    Overcome the challenges stemming from the CMS proposed Medicaid rebate rule

Benefit from the opportunity to hear directly from leading state AG offices and the US DOJ

Join Cynthia O'Keeffe, Deputy Chief, Civil Medicaid Fraud Division, Texas Office of the Attorney General, Gregg Shaprio, Assistant US Attorney, USDOJ, and Jay Shue, Deputy Attorney General, Director Medicaid Fraud Control Unit, Arkansas Office of the Attorney General, as they discuss critical elements of pricing litigation handled by state-appointed private outside counsel.  

Prepare to tackle emerging litigation trends and challenges by attending this unique and important event. Register by calling 1-888-224-2480, online at, or faxing your registration form to 1-877-927-1563.